Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits

作者: William D. Schwieterman , Edward A. Kesicki , Iain W. Duncan , Carl G. Osborne , Irina Jacobson

DOI:

关键词:

摘要: The present disclosure is directed to compositions and methods which utilize the tetracycline scaffold, preferably scaffold of or minocycline, significantly lack antibiotic activity. compounds have neuroprotective attributes without interfering with drugs capacity pass through blood brain barrier. These activity because their inhibition neuronal cell cycle progression. are characterized in part by a fifth ring joining positions 9 10.

参考文章(53)
Robert A. Ashley, Joseph J. Hlavaka, 4-dedimethylaminotracycline derivatives ,(2002)
Chitkala Satyanarayana, Dhanavanthri S Deevi, R Rajagopalan, Nanduri Srinivas, Sriram Rajagopal, None, DRF 3188 a novel semi-synthetic analog of andrographolide: cellular response to MCF 7 breast cancer cells. BMC Cancer. ,vol. 4, pp. 26- 26 ,(2004) , 10.1186/1471-2407-4-26
David Brian How, Joshua James Sabatini, Matthew Douglas Vera, Darrin William Hopper, Phaik-Eng Sum, Oxazole derivatives of tetracyclines ,(2004)
Joel Berniac, Paul Abato, Laura Honeyman, Haregewein Assefa, Todd Bowser, Mark Grier, Jackson Chen, 10-substituted tetracyclines and methods of use thereof ,(2006)
Jose M. Fiandor, Araceli Mallo, Roger Frechette, Mark L. Nelson, Carmen García-Luzón, Juan Carlos Cuevas, 9-aminoacyl tetracycline compounds and methods of use thereof ,(2006)
Mark L. Nelson, Mohamed Y. Ismail, Jackson Chen, Kwasi Ohemeng, Upul Bandarage, 3, 10, and 12a substituted tetracycline compounds ,(2003)